104 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMRN Amarin Corporation plc $2.83 $838.67M N/A
Article Searches
Spectrum Of Momentum Stocks Dominating The Early Returns For January https://seekingalpha.com/article/4232870-spectrum-momentum-stocks-dominating-early-returns-january?source=feed_all_articles Jan 11, 2019 - The spectrum of momentum portfolios have a strong lead among the Forensic Positive and Negative, Value and Anomaly stock portfolios I track from various published research studies.This follows my thes
Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference https://www.cnbc.com/2019/01/11/biotech-stocks-are-off-to-the-best-start-of-the-year-since-2012-.html Jan 11, 2019 - Two new deals to start the year and positive trial presentations at the J.P. Morgan Health Care conference have breathed new life into some of last year's biggest stock losers.
Amarin Corporation PLC (AMRN) CEO John Thero Presents at the 37th Annual JPMorgan Healthcare Conference (Transcript) https://seekingalpha.com/article/4232454-amarin-corporation-plc-amrn-ceo-john-thero-presents-37th-annual-jpmorgan-healthcare?source=feed_sector_transcripts Jan 09, 2019 - Amarin Corporation PLC. (NASDAQ:AMRN) 37th Annual JPMorgan Healthcare Conference January 09, 2019, 12:30 AM ET Company Participants John Thero - President and Chief Executive Officer Conference Call P
Amarin And The Art Of Low-Balling Guidance - Why 2019 Forecast Are Too Low https://seekingalpha.com/article/4232128-amarin-art-low-balling-guidance-2019-forecast-low?source=feed_sector_healthcare Jan 08, 2019 - Last Friday, Amarin announced preliminary 2018 results and 2019 revenue guidance of $350m, which is 16% below consensus estimates of $417m. This seems bearish, but the release seeps with bullishness.T
3 Things To Watch For Monday In Biotech Land https://seekingalpha.com/article/4231737-3-things-watch-monday-biotech-land?source=feed_sector_healthcare Jan 07, 2019 - The market managed to post solid gains in the first trading week of 2019, despite a steep decline on Thursday triggered by Apple's downward Q1 revenue guidance.The biotech sector easily outperformed t
Marketplace Authors' Top Picks For 2019 https://seekingalpha.com/article/4231231-marketplace-authors-top-picks-2019?source=feed Jan 06, 2019 - We wrap up our year-end Marketplace Roundtable series with a look forward, as we compile each of our participating Marketplace authors' best picks for 2019.The categories range from small caps to biot
Amarin: In Good Position To Capitalize On Exceptional REDUCE-IT Results https://seekingalpha.com/article/4227540-amarin-good-position-capitalize-exceptional-reduce-results?source=feed_sector_healthcare Dec 10, 2018 - Amarin's equity offering took place at $17.575 per share, resulting in minimal dilution.The dilution would reduce Amarin's upside by 1.4% (assuming a target price of $30 per share before).Vascepa saw
Amarin: A Poison Pill For The Miracle Pill https://seekingalpha.com/article/4227015-amarin-poison-pill-miracle-pill?source=feed_sector_healthcare Dec 07, 2018 - Sales reps joining Amarin's team already have the knowledge and expertise needed to successfully turn Vascepa into a global brand.Ireland prohibits takeover defenses such as the poison pill; therefore
Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock? http://www.zacks.com/stock/news/341740/are-options-traders-betting-on-a-big-move-in-amarin-amrn-stock?cid=CS-ZC-FT-341740 Dec 07, 2018 - Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.
Amarin Corporation plc (AMRN) CEO John Thero Presents at Citi's 2018 Global Healthcare Conference (Transcript) https://seekingalpha.com/article/4226601-amarin-corporation-plc-amrn-ceo-john-thero-presents-citis-2018-global-healthcare-conference?source=feed_sector_healthcare Dec 05, 2018 - Amarin Corporation plc (NASDAQ:AMRN) Citi’s 2018 Global Healthcare Conference December 5, 2018, 02:10 PM ET Executives John Thero - President and Chief Executive Officer Analysts Joel Beatty - Citigro

Pages: 123456...11

Page 1>

Related Companies

Name Exchange Price Mkt Cap
CTMX CytomX Therapeutics, Inc. NASDAQ $18.52 $832.73M
CARA Cara Therapeutics, Inc. NASDAQ $21.19 $832.56M
AMPH Amphastar Pharmaceuticals, Inc. NASDAQ $18.33 $847.88M
RVNC Revance Therapeutics, Inc. NASDAQ $23.5001 $868.04M
RDUS Radius Health, Inc. NASDAQ $17.78 $808.57M
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Amarin Corporation plc
AMRN - Google Finance https://www.google.com/finance?q=AMRN Industry related info and international coverage Summary News
AMRN - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=AMRN Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options